J Neurocrit Care.
2022 Dec;15(2):148-149. 10.18700/jnc.220081.
Longitudinal extensive transverse myelitis after COVID-19 vaccination (Spikevax mRNA-1273, Moderna) in a patient with rheumatoid arthritis
- Affiliations
-
- 1Department of Neurology, Hanyang University College of Medicine, Seoul, Korea
- KMID: 2538775
- DOI: http://doi.org/10.18700/jnc.220081
Figure
-
Fig. 1. (A) Initial brain fluid-attenuated inversion recovery (FLAIR) axial view images and spinal cord T2-weighted sagittal view images show high signal intensity lesions (arrows) compatible with longitudinal extensive transverse myelitis. (B) Spinal cord T2-weighted sagittal view images show interval improvement of high signal intensity lesions after steroid pulse therapy.
Reference
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Cases of Pernio-Like Lesions after mRNA-1273 Vaccination with Clinical and Pathological Features: A Single-Center Experience
- Large inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in health care workers
- A Case of Extensive Lichen Planus on Both Extremities Following mRNA-1273 Vaccination
- A Case of Exanthematous Drug Eruption Caused by mRNA-1273 (Moderna) SARS-CoV-2 Vaccine
- Adverse events following vaccination against coronavirus disease 2019
